ZIMMER BIOMET HOLDINGS INC (ZBH) Fundamental Analysis & Valuation
NYSE:ZBH • US98956P1021
Current stock price
91.26 USD
-1.18 (-1.28%)
At close:
91.26 USD
0 (0%)
After Hours:
This ZBH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZBH Profitability Analysis
1.1 Basic Checks
- In the past year ZBH was profitable.
- ZBH had a positive operating cash flow in the past year.
- In the past 5 years ZBH has always been profitable.
- In the past 5 years ZBH always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of ZBH (3.05%) is better than 75.94% of its industry peers.
- The Return On Equity of ZBH (5.55%) is better than 77.01% of its industry peers.
- With a decent Return On Invested Capital value of 5.79%, ZBH is doing good in the industry, outperforming 78.07% of the companies in the same industry.
- ZBH had an Average Return On Invested Capital over the past 3 years of 6.56%. This is below the industry average of 9.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| ROIC | 5.79% |
ROA(3y)4.02%
ROA(5y)2.97%
ROE(3y)7%
ROE(5y)5.22%
ROIC(3y)6.56%
ROIC(5y)5.98%
1.3 Margins
- Looking at the Profit Margin, with a value of 8.56%, ZBH belongs to the top of the industry, outperforming 81.28% of the companies in the same industry.
- ZBH's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 16.75%, ZBH belongs to the best of the industry, outperforming 87.17% of the companies in the same industry.
- In the last couple of years the Operating Margin of ZBH has grown nicely.
- The Gross Margin of ZBH (69.71%) is better than 77.54% of its industry peers.
- In the last couple of years the Gross Margin of ZBH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.75% | ||
| PM (TTM) | 8.56% | ||
| GM | 69.71% |
OM growth 3Y-1.75%
OM growth 5Y9.46%
PM growth 3Y36.96%
PM growth 5YN/A
GM growth 3Y-0.56%
GM growth 5Y0%
2. ZBH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZBH is destroying value.
- Compared to 1 year ago, ZBH has less shares outstanding
- The number of shares outstanding for ZBH has been reduced compared to 5 years ago.
- ZBH has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.41 indicates that ZBH is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.41, ZBH is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
- The Debt to FCF ratio of ZBH is 6.72, which is on the high side as it means it would take ZBH, 6.72 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of ZBH (6.72) is better than 73.26% of its industry peers.
- ZBH has a Debt/Equity ratio of 0.55. This is a neutral value indicating ZBH is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.55, ZBH is not doing good in the industry: 61.50% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.72 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.77
WACC7.49%
2.3 Liquidity
- A Current Ratio of 1.98 indicates that ZBH should not have too much problems paying its short term obligations.
- ZBH's Current ratio of 1.98 is on the low side compared to the rest of the industry. ZBH is outperformed by 64.17% of its industry peers.
- ZBH has a Quick Ratio of 1.10. This is a normal value and indicates that ZBH is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.10, ZBH is doing worse than 77.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.1 |
3. ZBH Growth Analysis
3.1 Past
- ZBH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.50%.
- Measured over the past 5 years, ZBH shows a small growth in Earnings Per Share. The EPS has been growing by 7.66% on average per year.
- The Revenue has been growing slightly by 7.20% in the past year.
- ZBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.22% yearly.
EPS 1Y (TTM)2.5%
EPS 3Y5.97%
EPS 5Y7.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y5.85%
Revenue growth 5Y3.22%
Sales Q2Q%10.9%
3.2 Future
- The Earnings Per Share is expected to grow by 6.07% on average over the next years.
- ZBH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.89% yearly.
EPS Next Y3.41%
EPS Next 2Y5.36%
EPS Next 3Y5.71%
EPS Next 5Y6.07%
Revenue Next Year4.21%
Revenue Next 2Y3.99%
Revenue Next 3Y3.89%
Revenue Next 5Y3.89%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ZBH Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 11.13, which indicates a very decent valuation of ZBH.
- Based on the Price/Earnings ratio, ZBH is valued cheaply inside the industry as 91.98% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of ZBH to the average of the S&P500 Index (27.42), we can say ZBH is valued rather cheaply.
- A Price/Forward Earnings ratio of 10.76 indicates a reasonable valuation of ZBH.
- 94.12% of the companies in the same industry are more expensive than ZBH, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of ZBH to the average of the S&P500 Index (22.29), we can say ZBH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.13 | ||
| Fwd PE | 10.76 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ZBH is valued cheaper than 91.98% of the companies in the same industry.
- ZBH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZBH is cheaper than 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.78 | ||
| EV/EBITDA | 9.94 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZBH does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of ZBH may justify a higher PE ratio.
PEG (NY)3.27
PEG (5Y)1.45
EPS Next 2Y5.36%
EPS Next 3Y5.71%
5. ZBH Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.04%, ZBH has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.25, ZBH pays a better dividend. On top of this ZBH pays more dividend than 92.51% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, ZBH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
5.2 History
- The dividend of ZBH has a limited annual growth rate of 0.12%.
- ZBH has paid a dividend for at least 10 years, which is a reliable track record.
- ZBH has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years13
5.3 Sustainability
- ZBH pays out 27.01% of its income as dividend. This is a sustainable payout ratio.
- The dividend of ZBH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP27.01%
EPS Next 2Y5.36%
EPS Next 3Y5.71%
ZBH Fundamentals: All Metrics, Ratios and Statistics
91.26
-1.18 (-1.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)04-28 2026-04-28/bmo
Inst Owners104.34%
Inst Owner Change-1.32%
Ins Owners0.17%
Ins Owner Change10.9%
Market Cap17.67B
Revenue(TTM)8.23B
Net Income(TTM)704.60M
Analysts66.47
Price Target105.44 (15.54%)
Short Float %5.18%
Short Ratio4.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
Yearly Dividend0.96
Dividend Growth(5Y)0.12%
DP27.01%
Div Incr Years0
Div Non Decr Years13
Ex-Date03-31 2026-03-31 (0.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.37%
Min EPS beat(2)0%
Max EPS beat(2)0.73%
EPS beat(4)4
Avg EPS beat(4)1.33%
Min EPS beat(4)0%
Max EPS beat(4)3.32%
EPS beat(8)6
Avg EPS beat(8)0.88%
EPS beat(12)9
Avg EPS beat(12)2.02%
EPS beat(16)13
Avg EPS beat(16)3.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)0.21%
Revenue beat(8)3
Avg Revenue beat(8)-0.3%
Revenue beat(12)5
Avg Revenue beat(12)0.36%
Revenue beat(16)9
Avg Revenue beat(16)0.9%
PT rev (1m)-0.15%
PT rev (3m)1.15%
EPS NQ rev (1m)0.37%
EPS NQ rev (3m)-2.78%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.13 | ||
| Fwd PE | 10.76 | ||
| P/S | 2.15 | ||
| P/FCF | 15.78 | ||
| P/OCF | 10.41 | ||
| P/B | 1.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.94 |
EPS(TTM)8.2
EY8.99%
EPS(NY)8.48
Fwd EY9.29%
FCF(TTM)5.78
FCFY6.34%
OCF(TTM)8.77
OCFY9.61%
SpS42.53
BVpS65.6
TBVpS-10.16
PEG (NY)3.27
PEG (5Y)1.45
Graham Number110.012 (20.55%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| ROCE | 6.72% | ||
| ROIC | 5.79% | ||
| ROICexc | 5.96% | ||
| ROICexgc | 22.61% | ||
| OM | 16.75% | ||
| PM (TTM) | 8.56% | ||
| GM | 69.71% | ||
| FCFM | 13.6% |
ROA(3y)4.02%
ROA(5y)2.97%
ROE(3y)7%
ROE(5y)5.22%
ROIC(3y)6.56%
ROIC(5y)5.98%
ROICexc(3y)6.74%
ROICexc(5y)6.13%
ROICexgc(3y)26.07%
ROICexgc(5y)24.68%
ROCE(3y)7.62%
ROCE(5y)6.94%
ROICexgc growth 3Y0.14%
ROICexgc growth 5Y10.7%
ROICexc growth 3Y1.16%
ROICexc growth 5Y14.26%
OM growth 3Y-1.75%
OM growth 5Y9.46%
PM growth 3Y36.96%
PM growth 5YN/A
GM growth 3Y-0.56%
GM growth 5Y0%
F-Score5
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.72 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 52.79% | ||
| Cap/Sales | 7.01% | ||
| Interest Coverage | 4.62 | ||
| Cash Conversion | 68.63% | ||
| Profit Quality | 158.91% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 2.41 |
F-Score5
WACC7.49%
ROIC/WACC0.77
Cap/Depr(3y)61.71%
Cap/Depr(5y)55.56%
Cap/Sales(3y)8.04%
Cap/Sales(5y)7.33%
Profit Quality(3y)115.26%
Profit Quality(5y)195.51%
High Growth Momentum
Growth
EPS 1Y (TTM)2.5%
EPS 3Y5.97%
EPS 5Y7.66%
EPS Q2Q%4.76%
EPS Next Y3.41%
EPS Next 2Y5.36%
EPS Next 3Y5.71%
EPS Next 5Y6.07%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y5.85%
Revenue growth 5Y3.22%
Sales Q2Q%10.9%
Revenue Next Year4.21%
Revenue Next 2Y3.99%
Revenue Next 3Y3.89%
Revenue Next 5Y3.89%
EBIT growth 1Y-11.53%
EBIT growth 3Y4%
EBIT growth 5Y12.99%
EBIT Next Year27.55%
EBIT Next 3Y10.42%
EBIT Next 5Y8.8%
FCF growth 1Y24.09%
FCF growth 3Y10.12%
FCF growth 5Y7.09%
OCF growth 1Y13.19%
OCF growth 3Y9.72%
OCF growth 5Y7.1%
ZIMMER BIOMET HOLDINGS INC / ZBH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ZIMMER BIOMET HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to ZBH.
Can you provide the valuation status for ZIMMER BIOMET HOLDINGS INC?
ChartMill assigns a valuation rating of 7 / 10 to ZIMMER BIOMET HOLDINGS INC (ZBH). This can be considered as Undervalued.
How profitable is ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a profitability rating of 7 / 10.
What is the financial health of ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The financial health rating of ZIMMER BIOMET HOLDINGS INC (ZBH) is 4 / 10.
What is the expected EPS growth for ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The Earnings per Share (EPS) of ZIMMER BIOMET HOLDINGS INC (ZBH) is expected to grow by 3.41% in the next year.